Source |
Code |
Name |
Case count |
Share of cases (%) |
PURCH |
PURCH_ATC(H05BA01) |
Calcitonin (salmon synthetic) |
1981 |
|
OUTPAT |
OUTPAT_ICD10(E2109) |
Other primary hyperparathyroidism |
1846 |
|
INPAT |
INPAT_ICD10(E2109) |
Other primary hyperparathyroidism |
1118 |
|
OUTPAT |
OUTPAT_ICD10(E210) |
Primary hyperparathyroidism |
784 |
|
OUTPAT |
OUTPAT_ICD10(E213) |
Hyperparathyroidism, unspecified |
647 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E2109) |
Other primary hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
463 |
|
PURCH |
PURCH_ATC(H05BX01) |
Cinacalcet |
364 |
|
INPAT |
INPAT_ICD10(E210) |
Primary hyperparathyroidism |
332 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E213) |
Hyperparathyroidism, unspecified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
324 |
|
INPAT |
INPAT_ICD10(E213) |
Hyperparathyroidism, unspecified |
311 |
|
OUTPAT |
OUTPAT_ICD10(E212) |
Other hyperparathyroidism |
269 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E210) |
Primary hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
202 |
|
OUTPAT |
OUTPAT_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified |
159 |
|
INPAT |
INPAT_ICD10(E212) |
Other hyperparathyroidism |
117 |
|
PURCH |
PURCH_ATC(H05BX02) |
Paricalcitol |
102 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E212) |
Other hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
76 |
|
INPAT |
INPAT_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified |
71 |
|
INPAT |
INPAT_ICD9(2520A) |
Hyperparathyroidism |
70 |
|
INPAT |
INPAT_ICD8(25200) |
Diseases of parathyroid gland, Hyperparathyroidism |
55 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
25 |
|
DEATH |
DEATH_ICD10(E210) |
Primary hyperparathyroidism |
6 |
|